Investors

OKYO Pharma is a bio-pharmaceutical company focused on the discovery & development of first-in-class pharmaceutical therapies to treat inflammatory eye diseases including neuropathic corneal pain.

NASDAQ:OKYO

Share Information

Shareholder Services

Investor Updates

SEC Filings

Corporate Governance

FAQs